FDA approves Lupin's generic diabetes drug

07/22/2013 | Business Standard (India) · RTT News

The FDA has granted Lupin Pharmaceuticals approval for its metformin hydrochloride extended-release tablets in 500 mg and 1,000 mg strengths to boost glycemic control in patients with type 2 diabetes. The drug is a generic version of Santarus' Glumetza HCl ER tablets.

View Full Article in:

Business Standard (India) · RTT News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID